Breaking News Instant updates and real-time market news.

10:25
04/19/21
04/19
10:25
04/19/21
10:25

Cowen basic materials analyst to hold an analyst/industry conference call

Basic Materials Analyst Gabelman, along with ClipperData's Head of Research, discusses waterborne petroleum shipments on an Analyst/Industry conference call to be held on April 19 at 11 am.

TODAY'S FREE FLY STORIES

Hot Stocks
Palantir announces extended commitment from U.S. Coast Guard » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
PLTR

Palantir

$21.17 /

-0.46 (-2.13%)

Palantir Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

04/22/21 Wolfe Research
Palantir initiated with a Peer Perform at Wolfe Research
03/15/21 Credit Suisse
Palantir assumed with an Underperform at Credit Suisse
02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

Earnings
Protara Therapeutics reports Q1 EPS ($1.20), consensus (73c) » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
TARA

Protara Therapeutics

$10.30 /

-0.08 (-0.77%)

"We remain on track…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Guggenheim
Protara Therapeutics started with Buy rating, $50 target at Guggenheim
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

  • 22
    Sep
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

Hot Stocks
Mogo in partnership with Tom Lee's Fundstrat for crypto research » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
MOGO

Mogo

$8.16 /

-0.02 (-0.24%)

Mogo announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

MOGO Mogo
$8.16 /

-0.02 (-0.24%)

03/24/21 Canaccord
Mogo price target raised to C$14 from C$13 at Canaccord
03/23/21 H.C. Wainwright
Outlook, Moka deal should 'drive excitement' about Mogo, says H.C. Wainwright
03/01/21 H.C. Wainwright
Mogo price target raised to $16 from $4 at H.C. Wainwright
02/11/21 Canaccord
Mogo downgraded to Hold from Speculative Buy at Canaccord
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

Upgrade
Jefferies upgrades Mercury Systems, sees growth intact despite disappointing Q3 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
MRCY

Mercury Systems

$57.72 /

-12.47 (-17.77%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

05:11 Today Jefferies
Mercury Systems upgraded to Buy from Hold at Jefferies
05/05/21
Fly Intel: Top five analyst downgrades
05/05/21 Canaccord
Canaccord downgrades Mercury Systems on lower growth outlook
05/05/21 Canaccord
Mercury Systems downgraded to Hold from Buy at Canaccord
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

Hot Stocks
Adaptimmune expects cash to fund operations into early 2023 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

The Company believes that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
CECO Environmental reports Q1 adjusted EPS 9c, consensus 9c » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
CECE

CECO Environmental

$7.47 /

+0.08 (+1.08%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

03/04/21 H.C. Wainwright
CECO Environmental price target raised to $15 from $9 at H.C. Wainwright
Earnings
Adaptimmune reports Q1 EPS (4c), consensus (25c) » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
Laureate Education reaffirms FY21 revenue $1B-$1.04B, two estimates $1B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Sees FY21 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Hot Stocks
EQT Corporation to acquire membership interests in Alta subsidiaries for $2.93B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
EQT

EQT Corporation

$20.19 /

+0.28 (+1.41%)

EQT Corporation announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

03/23/21 Goldman Sachs
EQT Corporation assumed with a Buy at Goldman Sachs
03/15/21 Piper Sandler
EQT Corporation price target raised to $22 from $18 at Piper Sandler
02/18/21 TD Securities
EQT Corporation price target raised to $24 from $20 at TD Securities
01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

  • 28
    Oct
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

Earnings
Black Knight raises FY21 adjusted EPS view to $2.16-$2.24 from $2.11-$2.22 » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
BKI

Black Knight

$71.42 /

-1.73 (-2.37%)

FY21 consensus $2.20.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

BKI Black Knight
$71.42 /

-1.73 (-2.37%)

04/19/21 Barclays
Black Knight shares nearing 'conviction buy levels,' says Barclays
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 Raymond James
Black Knight initiated with a Market Perform at Raymond James
02/17/21 Susquehanna
Susquehanna upgrades Black Knight to Positive as growth resumes
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

  • 17
    Jun
Earnings
Ranpak Holdings reports Q1 EPS 8c, consensus (2c) » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
PACK

Ranpak Holdings

$20.13 /

+0.445 (+2.26%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

04/26/21 Berenberg
Ranpak Holdings initiated with a Buy at Berenberg
04/19/21 Sidoti
Ranpak Holdings initiated with a Buy at Sidoti
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

Earnings
Brookfield Infrastructure Partners reports Q1 FFO 93c, consensus 87c » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
BIP

Brookfield Infrastructure Partners

$53.31 /

+0.36 (+0.68%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

02/11/21 Credit Suisse
Inter Pipeline upgraded to Neutral from Underperform at Credit Suisse
02/11/21 CIBC
Inter Pipeline upgraded to Outperformer from Neutral at CIBC
02/09/21 Barclays
Brookfield Infrastructure Partners price target raised to C$73 at Barclays
01/06/21 Wells Fargo
Brookfield Infrastructure downgraded to Equal Weight from Overweight at Wells Fargo
BIP Brookfield Infrastructure Partners
$53.31 /

+0.36 (+0.68%)

Earnings
Laureate Education reaffirms FY22 revenue 1.080B, two estimates $993.18M » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Sees FY21 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Hot Stocks
Intellia Therapeutics expects cash to fund requirements through next 24 months » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

Intellia expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Recommendations
Medallion Financial price target raised to $12 from $11 at B. Riley » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
MFIN

Medallion Financial

/

+

B. Riley analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MFIN Medallion Financial
/

+

MFIN Medallion Financial
/

+

04/07/21 B. Riley
Medallion Financial price target raised to $11 from $10 at B. Riley
02/19/21 B. Riley Securities
Medallion Financial price target raised to $10 from $8 at B. Riley Securities
11/24/20 B. Riley Securities
Medallion Financial resumed with a Buy at B. Riley Securities
MFIN Medallion Financial
/

+

Recommendations
SunPower price target lowered to $24 from $40 at Roth Capital » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
SPWR

SunPower

$23.28 /

+0.29 (+1.26%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

06:49 Today Barclays
SunPower price target lowered to $20 from $23 at Barclays
04/22/21 Barclays
SunPower price target lowered to $23 from $28 at Barclays
03/22/21 Goldman Sachs
SunPower downgraded to Neutral from Buy at Goldman Sachs
03/16/21 Morgan Stanley
Morgan Stanley says proposed California rules 'skew negative' for rooftop solar
SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

SPWR SunPower
$23.28 /

+0.29 (+1.26%)

Hot Stocks
Intellia Therapeutics announces anticipated milestones for 2021 » 07:48
05/06/21
05/06
07:48
05/06/21
07:48
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

The Company has set forth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Earnings
Xoma reports Q1 EPS (70c), consensus (16c) » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
XOMA

Xoma

$34.24 /

-2.11 (-5.80%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$34.24 /

-2.11 (-5.80%)

XOMA Xoma
$34.24 /

-2.11 (-5.80%)

01/19/21 H.C. Wainwright
Xoma price target raised to $56 from $30 at H.C. Wainwright
XOMA Xoma
$34.24 /

-2.11 (-5.80%)

Earnings
Intellia Therapeutics reports Q1 EPS (69c), consensus (66c) » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
NTLA

Intellia Therapeutics

$71.38 /

-0.64 (-0.89%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

05/03/21 RBC Capital
Intellia Therapeutics initiated with an Outperform at RBC Capital
03/04/21 JMP Securities
Intellia Therapeutics initiated with an Outperform at JMP Securities
02/26/21 Truist
Intellia Therapeutics price target raised to $80 from $40 at Truist
02/10/21 Chardan
Intellia Therapeutics price target raised to $85 from $57.50 at Chardan
  • 02
    Dec
  • 03
    Jun
NTLA Intellia Therapeutics
$71.38 /

-0.64 (-0.89%)

Recommendations
Avid Technology price target raised to $30 from $25 at B. Riley » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
AVID

Avid Technology

$21.75 /

-0.95 (-4.19%)

B. Riley analyst Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

03/17/21 RBC Capital
Avid Technology initiated with an Outperform at RBC Capital
03/10/21 B. Riley Securities
Avid Technology price target raised to $25 from $24 at B.Riley Securities
03/03/21 B. Riley Securities
Avid Technology price target raised to $24 from $18 at B. Riley Securities
02/09/21 Northland
Avid Technology price target raised to $32 from $22 at Northland
AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

AVID Avid Technology
$21.75 /

-0.95 (-4.19%)

Earnings
Laureate Education reports Q1 EPS (82c), one estimate (44c) » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Earnings
Black Knight reports Q1 adjusted EPS 56c, consensus 51c » 07:47
05/06/21
05/06
07:47
05/06/21
07:47
BKI

Black Knight

$71.42 /

-1.73 (-2.37%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

BKI Black Knight
$71.42 /

-1.73 (-2.37%)

04/19/21 Barclays
Black Knight shares nearing 'conviction buy levels,' says Barclays
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 Raymond James
Black Knight initiated with a Market Perform at Raymond James
02/17/21 Susquehanna
Susquehanna upgrades Black Knight to Positive as growth resumes
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

  • 17
    Jun
Earnings
International Seaways reports Q1 EPS (48c), consensus (55c) » 07:46
05/06/21
05/06
07:46
05/06/21
07:46
INSW

International Seaways

$18.53 /

-0.1 (-0.54%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSW International Seaways
$18.53 /

-0.1 (-0.54%)

INSW International Seaways
$18.53 /

-0.1 (-0.54%)

03/29/21 H.C. Wainwright
International Seaways initiated with a Buy at H.C. Wainwright
01/29/21 Jefferies
International Seaways price target lowered to $24 from $26 at Jefferies
10/21/20 BTIG
International Seaways downgraded to Neutral from Buy at BTIG
06/04/20 Pareto
International Seaways downgraded to Hold from Buy at Pareto
INSW International Seaways
$18.53 /

-0.1 (-0.54%)

Recommendations
Wingstop price target raised to $182 from $177 at Wells Fargo » 07:46
05/06/21
05/06
07:46
05/06/21
07:46
WING

Wingstop

$153.63 /

-6.52 (-4.07%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WING Wingstop
$153.63 /

-6.52 (-4.07%)

WING Wingstop
$153.63 /

-6.52 (-4.07%)

04/29/21 RBC Capital
Wingstop price target raised to $155 from $140 at RBC Capital
04/29/21 Wedbush
Wingstop price target raised to $180 from $175 at Wedbush
04/29/21 Barclays
Wingstop price target raised to $180 from $158 at Barclays
04/19/21 Stephens
Stephens starts Wingstop at Overweight with $172 price target
WING Wingstop
$153.63 /

-6.52 (-4.07%)

WING Wingstop
$153.63 /

-6.52 (-4.07%)

Earnings
BridgeBio reports Q1 EPS ($1.18), consensus (74c) » 07:46
05/06/21
05/06
07:46
05/06/21
07:46
BBIO

BridgeBio

$52.97 /

-1.04 (-1.93%)

"We measure success…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$52.97 /

-1.04 (-1.93%)

BBIO BridgeBio
$52.97 /

-1.04 (-1.93%)

03/22/21 Goldman Sachs
BridgeBio price target raised to $91 from $83 at Goldman Sachs
03/22/21 Piper Sandler
BridgeBio's encaleret likely to be new standard of care, says Piper Sandler
03/04/21 Mizuho
BridgeBio price target raised to $86 from $56 at Mizuho
03/01/21 Piper Sandler
BridgeBio's first approval small but significant, says Piper Sandler
BBIO BridgeBio
$52.97 /

-1.04 (-1.93%)

  • 12
    Feb
  • 29
    May
BBIO BridgeBio
$52.97 /

-1.04 (-1.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.